Top compounds associated with response to CTNND2


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA etoposide GDSC1000 pan-cancer AAC -0.036 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA CIL56 CTRPv2 pan-cancer AAC 0.047 0.3
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.032 0.3
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.052 0.3
mRNA CAY10594 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.033 0.3
mRNA Bortezomib FIMM pan-cancer AAC 0.15 0.3
mRNA ABT-888 CTRPv2 pan-cancer AAC 0.037 0.3
Download CSV